Skip to main navigation Skip to search Skip to main content

A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study of Pracinostat in Combination with Azacitidine in Patients 18 Years with Newly Diagnosed Acute Myeloid Leukemia unfit for Standard Induction Chemotherapy

Project: Research

Project Details

StatusFinished
Effective start/end date09/28/1707/23/19

Funding

  • Clinipace Worldwide: $10,529.25